The collaboration centers on colorectal cancer screening, surveillance and diagnostics. The new agreement focuses on Exact Sciences’ relationship with Mayo Clinic gastroenterologist and co-inventor of Cologuard David Ahlquist, MD.
“This unique collaboration is producing powerful results,” said John Noseworthy, MD, president and CEO of Mayo Clinic. “The success of our teams in developing Cologuard exemplifies what can happen when two organizations combine their expertise and unite toward a single goal.”
The original agreement dates back to June 11, 2009.
More articles on gastroenterology:
HCV outbreak confirmed at Tri-City Colonoscopy Clinic in Canada
6 gastroenterologists serving as CMOs
New drugs, screening tactics could nearly eliminate HCV by 2036
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
